IL20RB
Interleukin-20 receptor subunit beta
Also known as: DIRS1, FNDC6, I20RB_HUMAN, IL-20R2, MGC34923
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXL0
- Gene
- IL20RB
- Ensembl
- ENSG00000174564
- Chromosome
- 3
- Canonical length
- 311 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
IL20RB and IL20RA (MIM 605620) form a heterodimeric receptor for interleukin-20 (IL20; MIM 605619) (Blumberg et al., 2001 [PubMed 11163236]).[supplied by OMIM, Feb 2009]
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>Q6UXL0|IL20RB
1 MQTFTMVLEE IWTSLFMWFF YALIPCLLTD EVAILPAPQN LSVLSTNMKH LLMWSPVIAP
61 GETVYYSVEY QGEYESLYTS HIWIPSSWCS LTEGPECDVT DDITATVPYN LRVRATLGSQ
121 TSAWSILKHP FNRNSTILTR PGMEITKDGF HLVIELEDLG PQFEFLVAYW RREPGAEEHV
181 KMVRSGGIPV HLETMEPGAA YCVKAQTFVK AIGRYSAFSQ TECVEVQGEA IPLVLALFAF
241 VGFMLILVVV PLFVWKMGRL LQYSCCPVVV LPDTLKITNS PQKLISCRRE EVDACATAVM
301 SPEELLRAWI SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL20RB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 166 nTPM
Expression across tissuesHPA
Tissue
- skin: 166 nTPM
- esophagus: 121 nTPM
- vagina: 74 nTPM
- cervix: 58 nTPM
- salivary gland: 13 nTPM
- breast: 9.6 nTPM
Single-cell type
- esophageal apical cells: 547 nCPM
- esophageal suprabasal cells: 273 nCPM
- esophageal basal cells: 174 nCPM
- suprabasal keratinocytes: 142 nCPM
- basal keratinocytes: 102 nCPM
- ocular epithelial cells: 88 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 0.2 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- homeostasis of number of cells within a tissue
- immune response-inhibiting signal transduction
- inflammatory response to antigenic stimulus
- negative regulation of interleukin-2 production
- negative regulation of T cell proliferation
- negative regulation of type II interferon production
- negative regulation of type IV hypersensitivity
- positive regulation of interleukin-10 production
- positive regulation of interleukin-4 production
- T cell proliferation
- CD8-positive, alpha-beta T cell homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL20RB as an antibody target. Whether an autoantibody or antibody against IL20RB could matter depends on whether native IL20RB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL20RB is annotated at the cell surface, where native IL20RB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL20RB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...